Foley Partner Mark Waxman and Associate Geoffrey Raux authored an article that appeared in BNA’s Life Sciences Law & Industry Report on November 19, 2010 titled “Navigating Public Disclosures During Drug Development.”
Author(s)
Related Insights
06 May 2024
Health Care Law Today
50-State Survey of Telehealth Insurance Laws
Patients and health care professionals have been quick to adopt telemedicine and digital health technologies. In the last five years, the legal landscape for telehealth insurance coverage and reimbursement has expanded in several ways.
06 May 2024
Innovative Technology Insights
Bipartisan Proposal Would Not Tax Staking Rewards Until Time of Sale
The Providing Tax Clarity for Digital Assets Act would eliminate the mismatch in timing between acquisition of the reward and the receipt by a taxpayer of cash with which to pay the tax on the reward.
03 May 2024
Legal News: International Trade Enforcement & Compliance
Five Compliance Best Practices for … Conducting a Risk Assessment
Conducting an international risk assessment is crucial for identifying and mitigating potential risks associated with conducting business operations in foreign countries and complying with the expansive application of U.S. law.